Clinical Trials Browser

Interventional × Hepatocellular Carcinoma Non-resectable × sintilimab × Clear all

NCT05530785 2022-09-07

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Phase NA Unknown

Gastrointestinal

Hepatocellular Carcinoma Non-resectable